1. Barrowcliffe, T. W., Johnson, E. A. and Thomas, D. P. (1978). Antithrombin III and heparin. Br. Med. Bull., 34, 143
2. Basu, D., Gallus, A., Hirsh, J. and Cade, J. (1972). A prospective study of the value of monitoring heparin treatment with the activated partial thromboplastin time. N. Engl. J. Med., 287, 324
3. Bonnar, J. and Denson, K. W. E. (1973). Monitoring of heparin. Thromb. Diath. Haemorrh., 30, 471
4. Brozovic, M. and Bangham, D. R. (1975). Heparin structure, function and clinical implications. In Bradshaw, R. A. and Wessler, S. (eds.) Advances in Experimental Medicine and Biology, Vol. 52, pp. 163–79. (New York and London: Plenum Press)
5. Bull, M. H., Huse, W. M. and Bull, B. S. (1975). Evaluation of tests used to monitor heparin therapy during extracorporeal circulation. Anaesthesiology, 43, 346